Sponsor Pipeline

Lanyue Biotech (Hangzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07554924 A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal… Spinal Muscular Atrophy 1 Not Yet Recruiting
Disease Areas
Spinal Muscular Atrophy (1)
Get alerts when Lanyue Biotech (Hangzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free